Moderna (MRNA) Inventory (2020 - 2026)

Moderna has reported Inventory for 7 years, with the latest figure at $280.0 million in Q2 2026.

• Inventory for Q2 2026 came in at $280.0 million, up 16.67% year-over-year; the trailing twelve-month figure through Jun 2026 was $280.0 million (up 16.67% YoY), and the FY2025 annual result was $153.0 million, up 30.77% from the prior year.
• Inventory improved to $280.0 million in Q2 2026, from $146.0 million in the prior quarter.
• Over five years, Inventory peaked at $2.1 billion in Q3 2022 and troughed at $117.0 million in Q4 2024.
• A 5-year average of $640.4 million and a median of $365.5 million in 2024 frame the typical range for Inventory.
• The widest annual swing landed in 2022, when Inventory surged 293.12%; it then plunged 78.71% in 2023.
• A 5-year view of Inventory shows it stood at $949.0 million in 2022, then tumbled by 78.71% to $202.0 million in 2023, then plunged by 42.08% to $117.0 million in 2024, then soared by 30.77% to $153.0 million in 2025, then surged by 83.01% to $280.0 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $280.0 million in Q2 2026, $146.0 million in Q1 2026, and $153.0 million in Q4 2025.